Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-25T01:41:44.945Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (March 2008)

Published online by Cambridge University Press:  01 June 2008

R Sutherland
R Sutherland
Affiliation:
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 11 , Issue 6 , June 2008 , e11
Copyright
Copyright © Cambridge University Press 2008

References

1.Arendt, LM, Schuler, LA. Transgenic models to study actions of prolactin in mammary neoplasia. J Mammary Gland Biol Neoplasia 2008; 13: 29–40.CrossRefGoogle ScholarPubMed
2.Bai, T, Luoh, SW. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Carcinogenesis 2008; 29: 473–479.CrossRefGoogle ScholarPubMed
3.Boersma, BJ, Reimers, M, Yi, M, Ludwig, JA, Luke, BT, Stephens, RM, Yfantis, HG, Lee, DH, Weinstein, JN, Ambs, S. A stromal gene signature associated with inflammatory breast cancer. Int J Cancer 2008; 122: 1324–1332.CrossRefGoogle ScholarPubMed
4.Camps, C, Buffa, FM, Colella, S, Moore, J, Sotiriou, C, Sheldon, H, Harris, AL, Gleadle, JM, Ragoussis, J. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008; 14: 1340–1348.CrossRefGoogle ScholarPubMed
5.Cha, JY, Lambert, QT, Reuther, GW, Der, CJ. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis. Mol Cancer Res 2008; 6: 435–445.Google ScholarPubMed
6.Chanrion, M, Negre, V, Fontaine, H, Salvetat, N, Bibeau, F, Mac Grogan, G, Mauriac, L, Katsaros, D, Molina, F, Theillet, C, Darbon, JM. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res 2008; 14: 1744–1752.CrossRefGoogle ScholarPubMed
7.Cheang, MCU, Voduc, D, Bajdik, C, Leung, S, McKinney, S, Chia, SK, Perou, CM, Nielsen, TO. Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype. Clin Cancer Res 2008; 14: 1368–1376.CrossRefGoogle ScholarPubMed
8.Cortesio, CL, Chan, KT, Perrin, BJ, Burton, NO, Zhang, S, Zhang, ZY, Huttenlocher, A. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion. J Cell Biol 2008; 180: 957–971.CrossRefGoogle Scholar
9.Fitamant, J, Guenebeaud, C, Coissieux, MM, Guix, C, Trilleux, I, Scoazec, JY, Bachelot, T, Bernet, A, Mehlen, P. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 2008; 105: 4850–4855.CrossRefGoogle ScholarPubMed
10.Fletcher, O, Johnson, N, Gibson, L, Coupland, B, Fraser, A, Leonard, A, Silva, ID, Ashworth, A, Houlston, R, Peto, J. Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 702–705.CrossRefGoogle ScholarPubMed
11.Fournier, A, Fabre, A, Mesrine, S, Boutron-Ruault, MC, Berrino, F, Clavel-Chapelon, F. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008; 26: 1260–1268.CrossRefGoogle ScholarPubMed
12.Frank, B, Wiestler, M, Kropp, S, Hemminki, K, Spurdle, AB, Sutter, C, Wappenschmidt, B, Chen, XQ, Beesley, J, Hopper, JL, Meindl, A, Kiechle, M, Slanger, T, Bugert, P, Schmutzler, RK, Bartram, CR, Flesch-Janys, D, Mutschelknauss, E, Ashton, K, Salazar, R, Webb, E, Hamann, U, Brauch, H, Justenhoven, C, Ko, YD, Bruning, T, Silva, IDS, Johnson, N, Pharoah, PPD, Dunning, AM, Pooley, KA, Chang-Claude, J, Easton, DF, Peto, J, Houlston, R, Chenevix-Trench, G, Fletcher, O, Burwinkel, B. Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 2008; 100: 437–442.CrossRefGoogle Scholar
13.Gold, B, Kirchhoff, T, Stefanov, S, Lautenberger, J, Viale, A, Garber, J, Friedman, E, Narod, S, Olshen, AB, Gregersen, P, Kosarin, K, Olsh, A, Bergeron, J, Ellis, NA, Klein, RJ, Clark, AG, Norton, L, Dean, M, Boyd, J, Offit, K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22-33. Proc Natl Acad Sci USA 2008; 105: 4340–4345.CrossRefGoogle ScholarPubMed
14.Goodell, V, Waisman, J, Salazar, LG, dela Rosa, C, Link, J, Coveler, AL, Childs, JS, Fintak, PA, Higgins, DM, Disis, ML. Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity. Mol Cancer Ther 2008; 7: 449–454.CrossRefGoogle ScholarPubMed
15.Han, HJ, Russo, J, Kohwi, Y, Kohwi-Shigematsu, T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187–U36.CrossRefGoogle ScholarPubMed
16.Hanley, K, Wang, JM, Bourne, P, Yang, Q, Gao, AC, Lyman, G, Tang, P. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hum Pathol 2008; 39: 386–392.CrossRefGoogle ScholarPubMed
17.Hilton, HN, Stanford, PM, Harris, J, Oakes, SR, Kaplan, W, Daly, RJ, Ormandy, CJ. KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochim Biophys Acta-Mol Cell Res 2008; 1783: 383–393.CrossRefGoogle ScholarPubMed
18.Hu, P, Kinyamu, HK, Wang, LL, Martin, J, Archer, TK, Teng, C. Estrogen induces estrogen-related receptor α gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. J Biol Chem 2008; 283: 6752–6763.CrossRefGoogle ScholarPubMed
19.Huang, L, Cheng, HC, Isom, R, Chen, CS, Levine, RA, Pauli, BU. Protein kinase C-E mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis. J Biol Chem 2008; 283: 7616–7627.Google Scholar
20.Hurst, DR, Xie, Y, Vaidya, KS, Mehta, A, Moore, BP, Accavitti-Loper, MA, Samant, RS, Saxena, R, Silveira, AC, Welch, DR. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. J Biol Chem 2008; 283: 7438–7444.CrossRefGoogle ScholarPubMed
21.Kok, M, Linn, S, Laar, R, Jansen, M, Berg, T, Delahaye, L, Glas, A, Peterse, J, Hauptmann, M, Foekens, J, Klijn, J, Wessels, L, Veer, L, Berns, E. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2008; 10.1007/s10549-008-9939-y.Google ScholarPubMed
22.Laffin, B, Wellberg, E, Kwak, HI, Burghardt, RC, Metz, RP, Gustafson, T, Schedin, P, Porter, WW. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2. Mol Cell Biol 2008; 28: 1936–1946.CrossRefGoogle ScholarPubMed
23.Li, Z, Wang, C, Jiao, X, Katiyar, S, Casimiro, MC, Prendergast, GC, Powell, MJ, Pestell, RG. Alternate cyclin d1 mRNA splicing modulates p27(KIP1) binding and cell migration. J Biol Chem 2008; 283: 7007–7015.CrossRefGoogle ScholarPubMed
24.Molli, PR, Singh, RR, Lee, SW, Kumar, R. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene. Oncogene 2008; 27: 1971–1980.CrossRefGoogle ScholarPubMed
25.Oakes, SR, Naylor, MJ, Asselin-Labat, ML, Blazek, KD, Gardiner-Garden, M, Hilton, HN, Kazlauskas, M, Pritchard, MA, Chodosh, LA, Pfeffer, PL, Lindeman, GJ, Visvader, JE, Ormandy, CJ. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 2008; 22: 581–586.CrossRefGoogle ScholarPubMed
26.Rock, CL, Flatt, SW, Laughlin, GA, Gold, EB, Thomson, CA, Natarajan, L, Jones, LA, Caan, BJ, Stefanick, ML, Hajek, RA, Al-Delaimyl, WK, Stanczyk, FZ, Pierce, JP. Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 614–620.CrossRefGoogle ScholarPubMed
27.Rudas, M, Lehnert, M, Huynh, A, Jakesz, R, Singer, C, Lax, S, Schippinger, W, Dietze, O, Greil, R, Stigibauer, W, Kwasny, W, Grill, R, Stierer, M, Gnant, MFX, Filipits, M. Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. Clin Cancer Res 2008; 14: 1767–1774.CrossRefGoogle ScholarPubMed
28.Stuedal, A, Ma, H, Bernstein, L, Pike, MC, Ursin, G. Does breast size modify the association between marnmographic density and breast cancer risk? Cancer Epidemiol Biomarkers Prev 2008; 17: 621–627.CrossRefGoogle ScholarPubMed
29.Takahashi, M, Furihata, M, Akimitsu, N, Watanabe, M, Kaul, S, Yumoto, N, Okada, T. A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clin Exp Metastasis 2008; 10.1007/s10585-008-9163-5.CrossRefGoogle ScholarPubMed
30.Thorat, MA, Marchio, C, Morimiya, A, Savage, K, Nakshatri, H, Reis-Filho, JS, Badve, S. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis. J Clin Pathol 2008; 61: 327–332.CrossRefGoogle ScholarPubMed
31.Visscher, DW, Pankratz, VS, Santisteban, M, Reynolds, C, Ristimaki, A, Vierkant, RA, Lingle, WL, Frost, MH, Hartmann, LC. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 2008; 100: 421–427.CrossRefGoogle ScholarPubMed